Shkreli ordered to return $64M, is barred from drug industry

A federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life

Summary automatically generated by NewSUM A.I. from the following sources:

About the author